314 related articles for article (PubMed ID: 19648274)
1. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.
Goodman WA; Levine AD; Massari JV; Sugiyama H; McCormick TS; Cooper KD
J Immunol; 2009 Sep; 183(5):3170-6. PubMed ID: 19648274
[TBL] [Abstract][Full Text] [Related]
2. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.
Goodman WA; Young AB; McCormick TS; Cooper KD; Levine AD
J Immunol; 2011 Mar; 186(6):3336-45. PubMed ID: 21307288
[TBL] [Abstract][Full Text] [Related]
3. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
4. IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients.
Shi Y; Chen Z; Zhao Z; Yu Y; Fan H; Xu X; Bu X; Gu J
Front Immunol; 2019; 10():1865. PubMed ID: 31440249
[No Abstract] [Full Text] [Related]
5. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
7. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
Yang L; Li B; Dang E; Jin L; Fan X; Wang G
J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.
Zaba LC; Fuentes-Duculan J; Eungdamrong NJ; Abello MV; Novitskaya I; Pierson KC; Gonzalez J; Krueger JG; Lowes MA
J Invest Dermatol; 2009 Jan; 129(1):79-88. PubMed ID: 18633443
[TBL] [Abstract][Full Text] [Related]
9. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.
Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC
Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function.
Sconocchia T; Hochgerner M; Schwarzenberger E; Tam-Amersdorfer C; Borek I; Benezeder T; Bauer T; Zyulina V; Painsi C; Passegger C; Wolf P; Sibilia M; Strobl H
J Allergy Clin Immunol; 2021 May; 147(5):1810-1822.e9. PubMed ID: 33250156
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
12. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis.
Singh K; Gatzka M; Peters T; Borkner L; Hainzl A; Wang H; Sindrilaru A; Scharffetter-Kochanek K
J Immunol; 2013 Mar; 190(6):2544-53. PubMed ID: 23418628
[TBL] [Abstract][Full Text] [Related]
13. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.
Killeen ME; Ferris L; Kupetsky EA; Falo L; Mathers AR
J Immunol; 2013 Apr; 190(8):4324-36. PubMed ID: 23479230
[TBL] [Abstract][Full Text] [Related]
14. Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints.
Fiocco U; Martini V; Accordi B; Caso F; Costa L; Oliviero F; Scanu A; Felicetti M; Frallonardo P; Facco M; Boso D; Molena B; Zambello R; Ramonda R; Cozzi F; Scarpa R; Basso G; Semenzato G; Dayer JM; Doria A; Punzi L
J Rheumatol Suppl; 2015 Nov; 93():48-52. PubMed ID: 26523057
[TBL] [Abstract][Full Text] [Related]
15. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.
Schneider A; Long SA; Cerosaletti K; Ni CT; Samuels P; Kita M; Buckner JH
Sci Transl Med; 2013 Jan; 5(170):170ra15. PubMed ID: 23363979
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis.
Rodríguez-Jiménez P; Chicharro P; Llamas-Velasco M; Cibrian D; Trigo-Torres L; Vara A; Jiménez-Fernández M; Sevilla-Montero J; Calzada MJ; Sánchez-Madrid F; de la Fuente H; Daudén E
Front Immunol; 2019; 10():1268. PubMed ID: 31214201
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of IL-17 Producing Memory Regulatory and Effector T Cells Expressing CD26 Molecule in Patients with Psoriasis.
Esmaeili B; Mansouri P; Meysamie A; Izad M
Iran J Allergy Asthma Immunol; 2018 Oct; 17(5):453-463. PubMed ID: 30518187
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.
Sugiyama H; Gyulai R; Toichi E; Garaczi E; Shimada S; Stevens SR; McCormick TS; Cooper KD
J Immunol; 2005 Jan; 174(1):164-73. PubMed ID: 15611238
[TBL] [Abstract][Full Text] [Related]
20. Infiltration of T Cells into a Three-Dimensional Psoriatic Skin Model Mimics Pathological Key Features.
Lorthois I; Simard M; Morin S; Pouliot R
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
